Matches in Nanopublications for { ?s ?p "[Associations of epidermal growth factor (EGF) 61A>G, EGF receptor (EGFR) CA(14-22), cyclin D1 (CCND1) 932G>A, fragment-C gamma receptor (FCGR) 2A 535A>G and FCGR3A 818A>C polymorphisms with progression-free survival (PFS) and cetuximab-related skin toxicity were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP373419.RAXmZX7UsDAMIj90ff3Oaz0Op-xxeKO648qAAEPkYpaPA130_assertion description "[Associations of epidermal growth factor (EGF) 61A>G, EGF receptor (EGFR) CA(14-22), cyclin D1 (CCND1) 932G>A, fragment-C gamma receptor (FCGR) 2A 535A>G and FCGR3A 818A>C polymorphisms with progression-free survival (PFS) and cetuximab-related skin toxicity were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373419.RAXmZX7UsDAMIj90ff3Oaz0Op-xxeKO648qAAEPkYpaPA130_provenance.
- NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_assertion description "[Associations of epidermal growth factor (EGF) 61A>G, EGF receptor (EGFR) CA(14-22), cyclin D1 (CCND1) 932G>A, fragment-C gamma receptor (FCGR) 2A 535A>G and FCGR3A 818A>C polymorphisms with progression-free survival (PFS) and cetuximab-related skin toxicity were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211192.RAGIS_x1-hU7FfhMplRH-gY6y2AZ1168-i_4V7RGaj-Gs130_provenance.
- NP801014.RAXpt7nj1XD4_mr5oGx0e7gQyMv332a6XuCoXTg_jV6H8130_assertion description "[Associations of epidermal growth factor (EGF) 61A>G, EGF receptor (EGFR) CA(14-22), cyclin D1 (CCND1) 932G>A, fragment-C gamma receptor (FCGR) 2A 535A>G and FCGR3A 818A>C polymorphisms with progression-free survival (PFS) and cetuximab-related skin toxicity were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801014.RAXpt7nj1XD4_mr5oGx0e7gQyMv332a6XuCoXTg_jV6H8130_provenance.
- NP503887.RA8fr5y93Cki8X_VxcnI8IArlk8eWP2KfxXScR9gHwnP0130_assertion description "[Associations of epidermal growth factor (EGF) 61A>G, EGF receptor (EGFR) CA(14-22), cyclin D1 (CCND1) 932G>A, fragment-C gamma receptor (FCGR) 2A 535A>G and FCGR3A 818A>C polymorphisms with progression-free survival (PFS) and cetuximab-related skin toxicity were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503887.RA8fr5y93Cki8X_VxcnI8IArlk8eWP2KfxXScR9gHwnP0130_provenance.
- NP537050.RA7KWT5iT8zS7-ws9Z2ddXd4xjUdE3VH1rgo44tErwTCQ130_assertion description "[Associations of epidermal growth factor (EGF) 61A>G, EGF receptor (EGFR) CA(14-22), cyclin D1 (CCND1) 932G>A, fragment-C gamma receptor (FCGR) 2A 535A>G and FCGR3A 818A>C polymorphisms with progression-free survival (PFS) and cetuximab-related skin toxicity were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537050.RA7KWT5iT8zS7-ws9Z2ddXd4xjUdE3VH1rgo44tErwTCQ130_provenance.